Patient Square Capital

Patient Square Capital is a Menlo Park-based private equity firm built specifically around healthcare. The team partners with management at companies whose products and services are dedicated to clinical health outcomes — a narrower mandate than most generalist PE firms. Sub-verticals include care delivery, tech-enabled services, and pharma/therapeutics. AI is not the explicit thesis; Patient Square’s value is its concentrated healthcare expertise and the operating partners on the team who have run healthcare businesses themselves.

The firm deploys checks of $25M and above at the growth stage. That positions Patient Square as a lead investor for sizeable buyouts, take-privates, or growth equity placements in established healthcare companies. It is not a venture investor; founders earlier than a clear cash-flow or near-cash-flow story will not be the right fit.

Founders should approach Patient Square Capital when they run a mature healthcare business — care delivery, tech-enabled services, or therapeutics — that can absorb significant capital and benefit from operating-partner involvement. Early-stage technology plays, science-stage biotech, and pre-revenue companies are out of scope. Expect a partner that thinks about platform consolidation, executive bench-strengthening, and exit pathways rather than product iteration. Because the firm is purpose-built for healthcare, founders will get partners who already understand reimbursement, regulation, and the operational complexity of clinical businesses. Bring a clear plan for how growth or PE capital accelerates a specific operational or M&A thesis.